Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Multiple Sclerosis and Related Disorders
|
July 27, 2025
Exit strategies in patients with stable MS: Cost-effectiveness of extended interval dosing of ocrelizumab and natalizumab versus de-escalating to cladribine
Matthijs M Versteegh, Simone A Huygens
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 6, 2022
Effectiveness and Cost-Effectiveness of 360 Disease-Modifying Treatment Escalation Sequences in Multiple Sclerosis
Matthijs M Versteegh, Simone A Huygens, Beatrijs W H Wokke, et al.
Pharmacoeconomics
|
February 19, 2021
Methodological Challenges in the Economic Evaluation of a Gene Therapy for RPE65-Mediated Inherited Retinal Disease: The Value of Vision
Simone A Huygens, Matthijs M Versteegh, Stefan Vegter, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
March 8, 2017
Systematic review of model-based economic evaluations of heart valve implantations
Simone A Huygens, Johanna J M Takkenberg, Maureen P M H Rutten-van Mölken
Molecular Diagnosis & Therapy
|
April 14, 2024
Estimating the Prognostic Value of the NTRK Fusion Biomarker for Comparative Effectiveness Research in The Netherlands
Irene Santi, Heleen Vellekoop, Matthijs M Versteegh, et al.
Multiple Sclerosis and Related Disorders
|
November 9, 2023
Benefits of sphingosine-1-phosphate receptor modulators in relapsing MS estimated with a treatment sequence model
Cato E A Corsten, Simone A Huygens, Matthijs M Versteegh, et al.
Pharmacoeconomics
|
August 23, 2025
Cost-Utility Analysis of Treatment Sequences for Moderate-to-Severe Crohn's Disease
Matthijs M Versteegh, Simone A Huygens, Inigo Bermejo, et al.
Open Heart
|
March 14, 2018
How much does a heart valve implantation cost and what are the health care costs afterwards?
Simone A Huygens, Lucas M A Goossens, Judith A van Erkelens, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
March 22, 2024
How microsimulation translates outcome estimates to patient lifetime event occurrence in the setting of heart valve disease
Maximiliaan L Notenboom, Reda Rhellab, Jonathan R G Etnel, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
November 30, 2018
Beyond the clinical impact of aortic and pulmonary valve implantation: health-related quality of life, informal care and productivity†
Simone A Huygens, Frank van der Kley, Jos A Bekkers, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Multiple Sclerosis and Related Disorders
|
July 27, 2025
Exit strategies in patients with stable MS: Cost-effectiveness of extended interval dosing of ocrelizumab and natalizumab versus de-escalating to cladribine
Matthijs M Versteegh, Simone A Huygens
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 6, 2022
Effectiveness and Cost-Effectiveness of 360 Disease-Modifying Treatment Escalation Sequences in Multiple Sclerosis
Matthijs M Versteegh, Simone A Huygens, Beatrijs W H Wokke, et al.
Pharmacoeconomics
|
February 19, 2021
Methodological Challenges in the Economic Evaluation of a Gene Therapy for RPE65-Mediated Inherited Retinal Disease: The Value of Vision
Simone A Huygens, Matthijs M Versteegh, Stefan Vegter, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
March 8, 2017
Systematic review of model-based economic evaluations of heart valve implantations
Simone A Huygens, Johanna J M Takkenberg, Maureen P M H Rutten-van Mölken
Molecular Diagnosis & Therapy
|
April 14, 2024
Estimating the Prognostic Value of the NTRK Fusion Biomarker for Comparative Effectiveness Research in The Netherlands
Irene Santi, Heleen Vellekoop, Matthijs M Versteegh, et al.
Multiple Sclerosis and Related Disorders
|
November 9, 2023
Benefits of sphingosine-1-phosphate receptor modulators in relapsing MS estimated with a treatment sequence model
Cato E A Corsten, Simone A Huygens, Matthijs M Versteegh, et al.
Pharmacoeconomics
|
August 23, 2025
Cost-Utility Analysis of Treatment Sequences for Moderate-to-Severe Crohn's Disease
Matthijs M Versteegh, Simone A Huygens, Inigo Bermejo, et al.
Open Heart
|
March 14, 2018
How much does a heart valve implantation cost and what are the health care costs afterwards?
Simone A Huygens, Lucas M A Goossens, Judith A van Erkelens, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
March 22, 2024
How microsimulation translates outcome estimates to patient lifetime event occurrence in the setting of heart valve disease
Maximiliaan L Notenboom, Reda Rhellab, Jonathan R G Etnel, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
November 30, 2018
Beyond the clinical impact of aortic and pulmonary valve implantation: health-related quality of life, informal care and productivity†
Simone A Huygens, Frank van der Kley, Jos A Bekkers, et al.
Page
of 2